Betsson AB’s operating subsidiary is today launching 1X2 (EttKryssTvå), a product that could be seen as one of the biggest changes in the Swedish gaming market in 80 years. In 1X2 the customer bets on the outcome in 13 selected football matches with payout on 10, 11, 12 and 13 correct picks. The payout is guaranteed on both 10, 11, 12 and 13 correct picks, which is unique compared to other similar products on the market. The payout is odds based and not pool based, which means that it is determined by the player's own skill and not by how other players bet or if more players have the same, correct bets. The payout amount for 13 correct picks is reported before the game, which means that there will be no negative surprises on the payout. "Betsson thanks Svenska Spel for 80 years with the pool based game Stryktipset but now it’s time for another product, a better product. 1X2 is a more modern and more fair game where skill is highly rewarded." Says Magnus Silfverberg, CEO of Betsson AB. Betsson AB expects the new product to contribute to increased customer intake already during 2013. For further information, please contact: Magnus Silfverberg, CEO and President Betsson AB (publ), phone: +46 (0)8 506 403 00 or magnus.silfverberg@betssonab.com. Betsson AB’s Core Business consists of owning and administering shareholdings in companies which, themselves or through partners, offer gaming to the end users via the internet. Betsson AB owns Betsson Malta which operates gaming to the end users either through their own websites or through partnerships. Betsson Malta offers Poker, Casino, Sportsbook, Scratch Cards, Bingo and Games. The customers come primarily from the Scandinavian countries and other parts of Europe. Betsson AB is listed on NASDAQ OMX Nordic Mid Cap List, (BETS).
Betsson launches 1X2 (EttKryssTvå) Betsson AB’s
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
CENX Earnings Preview: Will Century Aluminum Deliver?
Century Aluminum (NASDAQ:CENX) is set to announce its quarterly earnings on February 19, 2026, and you can bet traders are glued to their screens waiting for that release. Analysts have thrown down an EPS estimate of $1.28, but here's the kicker—traders are notoriously jittery around these earnings announcements, especially after last quarter's $0.30 miss sent...
Continue Reading
Evolv Technology Forms Exciting Alliance with TGL Golf League
Exciting Collaboration Between Evolv Technology and Boston Common Golf Evolv Technology (NASDAQ: EVLV) has recently made headlines with its new partnership with Boston Common Golf, a prominent team within the innovative TGL golf league. This strategic alliance signifies Evolv as the Official Partner of the team, bringing its cutting-edge Evolv Express™ systems to the...
Continue Reading
Hatcher Landscape Partners Strengthens Future with GreenView Acquisition
Hatcher Landscape Partners Expands with Strategic Acquisition Hatcher Landscape Partners (HLP) has made a significant move by acquiring GreenView Partners, a respected firm in the landscape services arena. This acquisition is a strategic step towards establishing HLP as a leader in the commercial landscape industry. With backing from Walnut Grove Capital Partners, HLP...
Continue Reading
TTM Technologies Prepares for Fourth Quarter Results Call
Exciting Announcement from TTM Technologies, Inc. TTM Technologies, Inc. is making waves in the technology sector with its upcoming conference call scheduled for February 5, 2025. This call will focus on discussions regarding the company's performance for the fourth quarter and the entire fiscal year 2024. Join the Conference Call The conference call will kick off at 4:30...
Continue Reading
Investigation of Altimmune: What Investors Need to Know
Introduction to Faruqi & Faruqi's Investigation Faruqi & Faruqi, LLP, a prominent national securities law firm, has initiated an investigation regarding potential claims related to Altimmune, Inc. (NASDAQ: ALT). This inquiry targets investors who may have experienced losses due to the company's recent unfortunate announcements and stock performance. About Altimmune, Inc....
Continue Reading